Chularat Hospital PclSET: CHG

Notification of the resolutions of the Board of Directors' Meeting regarding the appointment of director to replace the resigned director and the postponement of joint investment in a new company. (Revised)

· Issued by Chularat Hospital Pcl

NO. CHG008/2022

May 20, 2022

Subject :

Notification of the resolutions of the Board of Directors' Meeting regarding the appointment of director

to replace the resigned director and the postponement of joint investment in a new company.(Revised)

To

:

Directors and Managers

The Stock Exchange of Thailand

Reference : No. CHG002/2022, Subject: The resolutions of the Board of Directors' Meeting regarding the Dividend payment, the schedule of the 2022 Annual General Meeting of Shareholders and the incorporation of Joint Investment on February 25, 2022

Chularat Hospital Public Company Limited ("Company") hereby reports the following significant resolutions of the Board of Directors' Meeting No.3/2022, which was held on May 12, 2022 at 09.30 hours as follows:

  1. Approved the Financial Statement for the first quarter of 2022 (Q1 2022) ended March 31, 2022.
  2. Acknowledged the resignation of Mr. Chayawat Pisessith, for the director, Independent Director, Audit Committee, Corporate Governance Committee And Nomination and Remuneration Committee of the Company, effective from May 12, 2022.
  3. Approved the appointment of Mr. Santhat Sanguandikul as the director, Independent Director, Audit Committee, Corporate Governance Committee And Nomination and Remuneration Committee of the Company to replace Mr. Chayawat Pisessith, the resigned director. The directorship term of the new director shall equal to the remaining term of the director whom he has replaced. Effective from May 13, 2022.
  4. Approved to postpone the joint investment in a new company, refer to the documents cited therein. If the Company is ready to invest, we will inform you again.

Please be informed accordingly.

Yours faithfully,

(Mr.Kriengsak Plussind )

Chairman of the Board

1

Company analysis